MedPath

The treatment of chronic obstructive lung disease

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease GOLD 0 is defined as patients with normal spirometry but with chronic symptoms such as cough and/or sputum production.
Respiratory
Registration Number
ISRCTN16377955
Lead Sponsor
niversity Hospital of Basel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
158
Inclusion Criteria

Both groups:
1. Able to give informed consent as documented by signature
2. Age =40 years
3. FEV1/FVC =0.70

Intervention group: Current or past smokers
4. =10 pack years
5. At least one symptom from the following: (Cough, Phlegm, Shortness of breath)

Control group: Minimal smoking exposure
6. =1 pack year tobacco-smoking history

Exclusion Criteria

Both groups:
1. Pregnant or lactating women
2. Current increased (more than usual) respiratory symptoms
3. Concomitant respiratory disease (eg asthma, ILD) or clinically significant bronchiectasis
4. Unstable cardiovascular disease
5. Inability to follow the procedures of the study, e.g. due to language problems, dementia, etc.
6. Active pulmonary infection or prior pulmonary infection where antibiotic and/or steroid treatment was completed =4 weeks prior to enrolment
7. Enrolment in an interventional clinical trial within last 30 days
8. Severe immunosuppression including manifested AIDS, organ transplantation, ongoing chemotherapy for cancer or neutropenia (<500*10^9/L)
9. Chronic use of oral steroids (>10 mg per day)

Intervention group:
10. Severe allergy to milk proteins
11. Known allergy or intolerance to the study medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Sacin/Scond measured using The nitrogen multiple-breath washout (N2MBW) at baseline and 3 months after start of medication<br> 2. R5-19 measured using the force impulse oscillometry at baseline and 3 months after start of medication<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath